NOV Stock Gains 32% in Six Months: Should Investors Hold or Move On?

NOV shares have risen 31.5% over the past six months, outperforming the broader oil and energy sector (22.4%), its sub-industry (24.1%), and peers USAC (15.1%) and OIS (21.8%). The bullish case centers on offshore and subsea backlog visibility into 2028, a planned $200 million Brazil expansion, and 2026 EPS growth expectations of 37.1% to 85 cents per share. Offsetting that are $54 million of Middle East-related revenue disruption in Q1, about $30 million of tariff headwinds, rising 2026 capex of $340 million-$370 million, and a 2.3% downgrade in the 2026 consensus EPS estimate over the last 30 days.

Analysis

NOV is trading like a cyclical upcycle beneficiary, but the market is increasingly paying for a 2027-2028 backlog story while near-term cash generation is being taxed by execution friction. That mismatch matters: when a capital goods name re-rates before margin normalization, the next leg usually depends less on order flow and more on whether working capital and free cash flow can stay resilient through inflationary noise. The real tell is whether offshore backlog converts without incremental cost creep; if it does, NOV can sustain a premium multiple, but if not, the recent outperformance becomes vulnerable to a valuation reset.

The second-order winner is likely not NOV alone but the offshore ecosystem around subsea, deepwater installation, and project logistics. Capacity additions in Brazil imply multi-year demand visibility, which can tighten specialized supply chains and support pricing for adjacent vendors; that benefits disciplined suppliers more than broad beta names. Conversely, any delay in Middle East project timing tends to hit the most operationally leveraged names first, so peers with less backlog and more spot exposure should underperform if disruption persists into the next 1-2 quarters.

The consensus appears to underappreciate how much of the bull case is now contingent on macro and policy stability rather than pure end-market demand. Tariffs and freight are not just margin headwinds; they also compress the ROI of the newly announced capacity, extending the payback period and making estimates more fragile. The market may also be too comfortable with the idea that cost-out will fully offset inflation by 2H26 — that is a long-dated promise, and the path there includes multiple execution checkpoints where guidance can be revised down again.

Key Decisions for Investors

• Stay tactically long NOV only on pullbacks, not momentum chase: preferred entry is any 5-8% retracement over the next 2-6 weeks; upside is a backlog-driven multiple hold, but downside is a 10-15% de-rating if revisions keep slipping.
• Pair long NOV / short a weaker offshore-exposed equipment peer basket on relative valuation, with a 3-6 month horizon; thesis is that NOV's backlog and cost discipline should outperform names with less visibility if offshore capex remains firm.
• For event risk, buy NOV downside protection through 1-2 quarter puts or put spreads ahead of the next earnings cycle; the catalyst is another revisions cut or margin miss from tariffs/logistics, which could compress the stock 8-12% quickly.
• Avoid chasing USAC as a clean beneficiary of offshore strength; if deepwater activity is the true driver, NOV should capture more of the capex dollar than compression-linked midstream equipment names, making USAC a lower-conviction relative long.
• Watch OIS as a higher-beta proxy for project timing: if Middle East disruption fades but offshore orders stay intact, OIS can outperform on sentiment; if disruptions persist, NOV is the higher-quality hold while OIS is the more vulnerable short-term fade.